Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2618-2621

  Düzgüneş, Nejat ^a,b   Flasher, Diana ^a   Reddy, M Venkata ^c   Luna Herrera, Julieta ^c   Gangadharam, Pattisapu R J ^c  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHOLESTEROL; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

AIDS RELATED COMPLEX; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

EID: 0029910034     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2618     Document Type: Article

References (36)

1. Agins, B. D., D. S. Berman, D. Spicehandler, W. El-Sadr, M. S. Simberkoff, and J. J. Rahal. 1989. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J. Infect. Dis. 159:784-787.
2. Armstrong, D., J. W. M. Gold, J. Drysanski, E. Whimbey, B. Polsky, C. Hawkins, A. E. Brown, E. Bernard, and T. K. Kiehn. 1985. Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 103:738-743.
3. Ashtekar, D., N. Düzgüneş, and P. R. J. Gangadharam. 1991. Activity of free and liposome-encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. J. Antimicrob. Chemother. 28: 615-617.
4. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234:466-468.
5. Benson, C. 1994. Disseminated Mycobacterium avium complex disease in patients with AIDS. AIDS Res. Hum. Retroviruses 10:913-916.
6. Bermudez, L. E., A. O. Yau-Young, J.-P. Lin, J. Cogger, and L. S. Young. 1990. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. J. Infect. Dis. 161: 1262-1268.
7. Chin, D. P., A. L. Reingold, E. N. Stone, E. Vittinghoff, C. R. Horsburgh, Jr., E. M. Simon, D. M. Yajko, W. K. Hadley, S. M. Ostroff, and P. C. Hopewell. 1994. The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients - a prospective study. J. Infect. Dis. 170:578-584.
8. Daleke, D. L., K. Hong, and D. Papahadjopoulos. 1990. Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim. Biophys. Acta 1024:352-366.
9. Dijkstra, J., W. J. M. van Galen, C. E. Hulstaert, D. Kalicharan, F. H. Roerdink, and G. L. Scherphof. 1984. Interaction of liposomes with Kupffer cells in vitro. Exp. Cell Res. 150:161-176.
10. Düzgüneş, N., D. R. Ashtekar, D. L. Flasher, N. Ghori, R. J. Debs, D. S. Friend, and P. R. J. Gangadharam. 1991. Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment. J. Infect. Dis. 164:143-151.
11. Düzgüneş, N., V. K. Perumal, L. Kesavalu, J. A. Goldstein, R. J. Debs, and P. R. J. Gangadharam. 1988. Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex in beige mice. Antimicrob. Agents Chemother. 32:1404-1411.
12. Fattorini, L., B. Li, C. Piersimoni, E. Tortoli, Y. Xiao, C. Santoro, M. L. Ricci, and G. Orefici. 1995. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. Antimicrob. Agents Chemother. 39:680-685.
13. Gangadharam, P. R. J., D. A. Ashtekar, N. Ghori, J. A. Goldstein, R. J. Debs, and N. Düzgüneş. 1991. Chemotherapeutic potential of free and liposome-encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. J. Antimicrob. Chemother. 28:425-435.
14. Hawkins, C. C., J. W. M. Gold, E. Whimbey, T. E. Kiehn, P. Brannon, R. Cammarata, A. E. Brown, and D. Armstrong. 1986. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:184-188.
15. Henderson, H. M., and S. W. Chapman. 1994. Mycobacterium avium-intracellulare. Curr. Opin. Infect. Dis. 7:225-230.
16. Horsburgh, C. R., U. G. Mason III, D. C. Farhi, and M. D. Iseman. 1985. Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine (Baltimore) 64:36-48.
17. Horsburgh, C. R., and R. M. Selik. 1989. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir. Dis. 139:4-7.
18. Horsburgh, C. R., Jr. 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:1332-1338.
19. Horsburgh, C. R., Jr., D. L. Cohn, R. B. Roberts, H. Masur, R. A. Miller, A. Y. Tsang, and M. D. Iseman. 1986. Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome. Antimicrob. Agents Chemother. 30:955-957.
20. Kesavalu, L., J. A. Goldstein, R. J. Debs, N. Düzgüneş, and P. R. J. Gangadharam. 1990. Differential effects of free and liposome encapsulated amikacin on the growth of Mycobacterium avium complex in mouse peritoneal macrophages. Tubercle 71:215-218.
21. Klemens, S. P., M. H. Cynamon, C. E. Swenson, and R. S. Ginsberg. 1990. Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob. Agents Chemother. 34:967-970.
22. Klopman, G., S. Wang, M. R. Jacobs, S. Bajaksouzian, K. Edmonds, and J. J. Ellner. 1993. Anti-Mycobacterium avium activity of quinolones: in vitro activities. Antimicrob. Agents Chemother. 37:1799-1806.
23. Lee, K.-D., S. Nir, and D. Papahadjopoulos. 1993. Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry 32:889-899.
24. Majumdar, S., D. Flasher, D. S. Friend, P. Nassos, D. Yajko, W. K. Hadley, and N. Düzgüneş. 1992. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob. Agents Chemother. 36:2808-2815.
25. Masur, H., C. Tuazon, V. Gill, G. Grimes, B. Baird, A. S. Fauci, and H. C. Lane. 1987. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. J. Infect. Dis. 155:127-129.
26. Mehta, R. T., A. Keyhani, T. J. McQueen, B. Rosenbaum, K. V. Rolston, and J. J. Tarrand. 1993. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob. Agents Chemother. 37:2584-2587.
27. Oh, Y. K., D. E. Nix, and R. M. Straubinger. 1995. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Antimicrob. Agents Chemother. 30:2104-2111.
28. Onyeji, C. O., C. H. Nightingale, D. P. Nicolau, and R. Quintiliani. 1994. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. Antimicrob. Agents Chemother. 38:523-527.
29. Perronne, C., A. Gikas, C. Truffot-Pernot, J. Grosset, J.-L. Vilde, and J.-J. Pocidalo. 1991. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. Antimicrob. Agents Chemother. 35:1356-1359.
30. Poste, G., C. Bucana, A. Raz, P. Bugelski, R. Kirsh, and I. J. Fidler. 1982. Analysis of systemically administered liposomes and implications for their use in drug delivery. Cancer Res. 42:1412-1422.
31. Rastogi, N., V. Labrousse, K. S. Goh, and J. P. Carvalho de Sousa. 1991. Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. Antimicrob. Agents Chemother. 35:2473-2480.
32. Roerdink, F., J. Regts, T. Daemen, I. Bakker-Woudenberg, and G. Scherphof. 1986. Liposomes as drug carriers to liver macrophages: fundamental and therapeutic aspects, p. 193-206. In G. Gregoriadis, J. Senior, and G. Poste (ed.), Targeting of drugs with synthetic systems. Plenum Press, New York.
33. Spencer, P. M., and G. G. Jackson. 1989. Fungal and mycobacterial infections in patients infected with the human immunodeficiency virus. J. Antimicrob. Chemother. 23(Suppl. A):107-125.
34. Tomioka, H., H. Saito, K. Sato, and T. Yoneyama. 1991. Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice. Am. Rev. Respir. Dis. 144:575-579.
35. Yajko, D. M., C. A. Sanders, P. S. Nassos, and W. K. Hadley. 1990. In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. Antimicrob. Agents Chemother. 34:2442-2444.
36. Young, L. S., C. B. Inderlied, O. G. Berlin, and M. S. Gottlieb. 1986. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev. Infect. Dis. 8:1024-1033.